Missed opportunities for Hepatitis B vaccination among diabetic patients


ÖZIŞIK L., Tanriover M. D. , Basaran N. C. , ÖZ Ş. G. , ÜNAL S.

HUMAN VACCINES & IMMUNOTHERAPEUTICS, vol.11, no.12, pp.2806-2810, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 12
  • Publication Date: 2015
  • Doi Number: 10.1080/21645515.2015.1070999
  • Journal Name: HUMAN VACCINES & IMMUNOTHERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.2806-2810
  • Keywords: diabetes, hepatitis B vaccine, hepatitis B, seroprevalance, vaccination, VIRUS INFECTION, PREVALENCE, MELLITUS

Abstract

Many infectious diseases in adults can be prevented by a life-long vaccination strategy'. Hepatitis B disease burden was shown to be higher in diabetic patients. American Advisory Committee on Immunization Practices recommends to vaccinate diabetic patients against hepatitis B since 2011. In this study, we aimed to determine hepatitis B virus serology status to determine the rates of diabetic patients who have indications for hepatitis B vaccination. The electronic database of the hospital was searched to identify adult patients aged above 18years and with hemoglobin A(1)C levels of 6.5% or above, who have been seen at General Medicine Outpatient Clinics of a university hospital during a 3-year period. A total of 5187 patients were included in the study. After exclusion of patients with an incomplete serological panel, 1358 patients were included for further analyses. Twenty-nine percent of the patients had indication for hepatitis B vaccination, whereas only 8% were vaccinated. This study showed that nearly one third of patients who had hepatitis B serological data had an indication for hepatitis B vaccination and this is a clear reflection of the need to keep a lifelong vaccination log and inquire vaccination data.